About Pfizer Inflammation & Immunology
At Pfizer Inflammation & Immunology, we strive to deliver breakthroughs that enable freedom from day-to-day suffering for people living with autoimmune and chronic inflammatory diseases, which can be debilitating, disfiguring, and distressing. With a focus on Rheumatology, Gastroenterology, and Medical Dermatology, our current portfolio of approved medicines and investigational molecules spans multiple action and delivery mechanisms, from topicals to small molecules to biologics to biosimilars.
Our differentiated R&D approach has resulted in one of the broadest pipelines in the industry, where we purposefully match molecules to diseases for which we believe they can make the biggest difference. Building on our decades-long commitment and pioneering science, we continue to advance research with the goal of creating life-changing impact for patients with these debilitating diseases and are working hand-in-hand with patients, caregivers, and the broader healthcare community on healthcare solutions for the many challenges of managing chronic inflammatory diseases.